Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a fixed-dose combination product containing pantoprazole, amoxicillin, and clarithromycin. It is a proton pump inhibitor (PPI), a penicillin-class antibiotic, and a macrolide antibiotic, respectively.
## Primary Indications
Sompraz HP is indicated for the eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The standard adult dose is one kit taken twice daily for 7 to 14 days. Each kit typically contains:
* Pantoprazole 40 mg
* Amoxicillin 500 mg
* Clarithromycin 500 mg
The specific duration of therapy may vary based on local guidelines or physician preference.
## Pediatric Dosing
Dosing for pediatric patients is not well-established and should be determined by a specialist based on the individual patient's weight and clinical condition.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically recommended for pantoprazole or clarithromycin in mild to moderate renal impairment. However, caution is advised. Amoxicillin may require dose adjustment in severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** No dose adjustment is typically recommended for pantoprazole in mild to moderate hepatic impairment. For severe hepatic impairment, dose reduction may be considered. Clarithromycin may require dose adjustment in moderate to severe hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, other macrolides, or penicillins.
* History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with ergotamine or dihydroergotamine.
* Patients with known heart rhythm abnormalities or QT prolongation.
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, headache, dizziness, rash, and taste disturbances. Serious adverse effects may include severe allergic reactions, *Clostridium difficile*-associated diarrhea, QT prolongation (especially with clarithromycin), hepatotoxicity, and emergence of antibiotic resistance.
## Key Drug Interactions
* **Pantoprazole:** Can decrease the absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, certain antiretrovirals). May increase the risk of fractures with long-term use.
* **Clarithromycin:** Potent inhibitor of CYP3A4, increasing concentrations of numerous drugs including statins, warfarin, cyclosporine, tacrolimus, certain anticonvulsants, and theophylline. Avoid coadministration with colchicine, lovastatin, simvastatin, and pimozide.
* **Amoxicillin:** May reduce the effectiveness of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Assess for effectiveness in *H. pylori* eradication (e.g., urea breath test, stool antigen test) after completion of therapy.
* Monitor for diarrhea and signs of *Clostridium difficile* infection.
* Consider ECG monitoring if risk factors for QT prolongation are present during clarithromycin therapy.
* Monitor liver function tests, particularly in patients with pre-existing liver disease or those on prolonged therapy.
## Clinical Pearls
* This combination product is designed to simplify the multi-drug regimen for *H. pylori* eradication.
* Ensure patients complete the full course of therapy, even if symptoms improve, to ensure eradication and prevent resistance.
* Advise patients to take pantoprazole 30-60 minutes before breakfast. The antibiotics should be taken with meals to minimize gastrointestinal upset.
* Consider potential penicillin allergies and cross-reactivity.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date information before making clinical decisions.
